Adage Capital Partners Gp, L.L.C. Ikena Oncology, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 800,000 shares of IKNA stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800,000
Previous 987,900
19.02%
Holding current value
$1.11 Million
Previous $1.71 Million
23.23%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IKNA
# of Institutions
55Shares Held
31.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.98 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.69 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.57 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.98 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.92 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $50.4M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...